Out For Tender

Out For TenderCanadáEquipamento médico, medicamentos e produtos para cuidados pessoais

Request For Proposal (RFP) for Pharmacological testing of novel opioids, stimulants, and synthetic cannabinoids.

Entidade adjudicante
Department of Health (HC)
País
Canadá
Categoria
Equipamento médico, medicamentos e produtos para cuidados pessoais
Prazo
Termina amanhã (25 Sep 2026 12:00 UTC-7)
Publicado
20 Aug 2026
Procedimento
Competitive - Open bidding

Ler o anúncio oficial e concorrer → As propostas são sempre apresentadas no portal da entidade adjudicante, nunca aqui.

O que a entidade adjudicante procura

Request For Proposal (RFP) for Pharmacological testing of novel opioids, stimulants, and synthetic cannabinoids. Amendment 1 - Questions & Answers #1 and Amendment to Annex B - SOW Stream 2 Amendment 2 - Questions & Answers #2 and Amendment to Annex A - SOW Stream 1 Novel psychoactive substances (NPS) in the illegal drug supply pose risks to Canadians. However, little is known about their pharmacological activity. More potent drugs increase the risk of overdose risks. Evidence on the pharmacological activity of these substances is essential to support scientific regulatory activities and risk assessments. The illegal drug supply is continuously evolving, with new substances continually being detected. There is a need for further information on their harms to Canadians. This procurement activity will allow for the evaluation of the in vitro pharmacological activity of three categories of emerging drugs: novel synthetic opioids, synthetic cannabinoids, and stimulants. The data generated from this contract will inform future assessment activities and allow the Office of Legislative and Regulatory Affairs (OLRA) to make more informed regulatory science decisions. For all three streams, they require the pharmacological testing of different classes of substances, and require acquisition of reference standards and control samples, getting licenses for controlled substances, conducting experiments (including doing statistical analysis), and finally drafting and finalizing reports. Canada is seeking offers from Offerors to provide Pharmacological Testing for Novel Opioids, Stimulants, and Synthetic Cannabinoids in three (3) separate streams to Health Canada. Stream 1 - In vitro pharmacological testing of emerging opioids at the Mu Opioid Receptor (MOR). Stream 2 – In vitro pharmacological testing of novel synthetic cannabinoids and Stream 3 – In vitro pharmacological testing of stimulant compounds. Each stream will be evaluated separately, and bidders are to provide their submissions for one (1) stream, two (2) streams or all three (3) streams. Up to three (3) contracts may be awarded under this request for proposal.

Idioma deste anúncio: English. O título e a descrição são apresentados tal como a entidade adjudicante os publicou.

Este concurso noutras línguas

  • FR Demande de propositions (DP) pour des tests pharmacologiques sur de nouveaux opioïdes, stimulants et cannabinoïdes synthétiques.

Source: CANADABUYS · reference cb-93-39360034 · JSON